ArticleEuropean journal of pain (London, England)2026
Musculoskeletal Pain, Insomnia and Health-Related Quality of Life: Associations in the Middle-Aged General Population.
Article in European journal of pain (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Musculoskeletal Pain, Insomnia and Health-Related Quality of Life: Associations in the Middle-Aged General Population.European journal of pain (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMusculoskeletal (MSK) pain and insomnia are interrelated and individually linked to reduced health-related quality of life (HRQoL). This study aimed to enlighten the association of concurrent disabling MSK pain and insomnia with HRQoL among middle-aged individuals.
methodsMembers of the Northern Finland Birth Cohort 1966 were surveyed at age 46 years (analytic sample N = 4 130, 56.7% women). Validated Athens insomnia scale was used to determine insomnia status and HRQoL was assessed with the 15D (15-dimensional) questionnaire. Associations between different combinations of disabling MSK pain and insomnia (concurrent, isolated, absent) with HRQoL were analysed using general linear regression, adjusting for sex, smoking, educational level, physical activity and coexisting diseases. Fifteen HRQoL dimensions were also analysed separately.
resultsThe prevalence of concurrent disabling MSK pain and insomnia was 14.3%, while 50.8% reported neither condition. Adjusted 15D mean score of participants with concurrent disabling MSK pain and insomnia was significantly lower (beta [β] coefficient: -0.068 [95% CI -0.073 to -0.062]) compared to those without. Concurrent conditions were associated with lower HRQoL than isolated insomnia and isolated disabling MSK pain (β coefficients: -0.032 [95% CI -0.039 to -0.024] and -0.042 [95% CI -0.050 to -0.034], respectively). Fourteen of 15 HRQoL dimensions were the lowest among participants with concurrent conditions.
conclusionsThis study shows that every seventh of the study population has disabling MSK pain and insomnia concurrently and they are more strongly associated with lower HRQoL compared to isolated or absent conditions. The negative effects of comorbid conditions on HRQoL are reflected across multiple dimensions. SIGNIFICANCE STATEMENT: Musculoskeletal pain and insomnia together exert a compounded negative effect on health-related quality of life, highlighting the need for integrated management strategies. Treating pain alone may not be enough and routine sleep assessment could be a critical point.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.